Evidence map›Paper›PMID 20177374›Full record

ArticleBehavioural pharmacology2010

Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.

Ellen A Walker, John J Foley

Abstract read
In one paragraph

Article in Behavioural pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Serotonin, neural markers, and memory.Frontiers in pharmacology · 2015
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ellen A WalkerDepartment of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA. ellen.walker@temple.edu
John J Foley

Funding

Effects of chemotherapeutic agents on learning and memory in miceR01CA129092 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI WALKER, ELLEN ANN · 2009 to 2013
$1.5M
Behavioral Pharmacology of Serotonin Inverse AgonistsR01DA014673 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI WALKER, ELLEN ANN · 2002 to 2006
$1.4M
NCI NIH HHS R01 CA129092NIDA NIH HHS DA14673NIDA NIH HHS R01 DA014673
6 · The paper itself

Abstract

Although the neurotransmitter, 5-hydroxytryptamine (serotonin, 5-HT), has been implicated as a mediator of learning and memory, the specific role of 5-HT receptors in rodents requires further delineation. In this study, 5-HT2C receptor ligands of varying relative intrinsic efficacies were tested in a mouse learning and memory model called autoshaping-operant. On day 1, mice were placed in experimental chambers and presented with a tone on a variable interval schedule. The tone remained on for 6 s or until a nose-poke response occurred to produce a dipper with Ensure solution. Mice were then injected with saline, MK212 (full agonist), m-chlorophenylpiperazine (partial agonist), mianserin, and SB206 553 (inverse agonists), and methysergide and (+)-2-bromo lysergic acid diethylamide (+)-hydrogen tartrate (neutral antagonists). Each compound was injected after either 1 or 2-h acquisition sessions on day 1 to investigate the role of acquisition session length on consolidation. Day 1 injection of the 5-HT2C inverse agonist mianserin produced greater retrieval impairments of the autoshaped operant response on day 2 than any other agent tested. Furthermore, decreasing the length of the acquisition session to 1h significantly increased the difficulty of the autoshaping task further modulating the consolidation effects produced by the 5-HT2C ligands tested.

Indexed as

Serotonin 5-HT2 Receptor AgonistsSerotonin 5-HT2 Receptor AntagonistsAnimalsConditioning, OperantDose-Response Relationship, DrugDrug Inverse AgonismDrug Partial AgonismIndolesLigandsLysergic Acid DiethylamideMaleMemoryMethysergideMianserinMicePiperazines1-(3-chlorophenyl)piperazine2-bromolysergic acid diethylamide6-chloro-2-(1-piperazinyl)pyrazineIndolesLigandsLysergic Acid DiethylamideMethysergideMianserinPiperazinesPyrazinesPyridinesSB 206553Serotonin 5-HT2 Receptor AgonistsSerotonin 5-HT2 Receptor AntagonistsSerotonin AntagonistsSerotonin Receptor Agonists

Identifiers

PMID20177374
PMCPMC6511452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.